Ginkgo Bioworks DNA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$297.87M+4.8% | -$312.76M+7.9% | -$339.55M-7.7% | -$315.19M+33.2% | -$472.08M+13.7% | ||
| $56.97M-3.4% | $58.99M-3.3% | $60.98M-4.7% | $63.98M-1.5% | $64.97M+3.1% | ||
| $80.01M-1.9% | $81.55M+0.6% | $81.08M+5.2% | $77.09M-13.3% | $88.95M-20.8% | ||
| -$166.22M+2.8% | -$171.06M-3.2% | -$165.82M+30.2% | -$237.71M+15.7% | -$281.85M+11.8% | ||
| $1.98M-74.2% | $7.67M-64.1% | $21.37M-41.4% | $36.46M-42.5% | $63.45M+1.5% | ||
| —— | —— | -$348.47M-21.9% | -$285.86M-14.9% | -$248.81M-300% | ||
| $17.96M+1.1% | $17.78M+88.5% | $9.43M+1,069% | -$973K+11.6% | -$1.1M+36.7% | ||
| —— | —— | -$504.58M+3.8% | -$524.39M+1.4% | -$531.81M-38.5% | ||
| -$168.2M+5.9% | -$178.72M+4.5% | -$187.19M+31.7% | -$274.17M+20.6% | -$345.3M+9.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ginkgo Bioworks generate?
- Ginkgo Bioworks (DNA) generated -$166.2M in operating cash flow over the trailing twelve months.
- What is Ginkgo Bioworks's free cash flow?
- After $2.0M of capital expenditures, Ginkgo Bioworks's free cash flow was -$168.2M over the trailing twelve months, up 51.3% year over year.
- Where does Ginkgo Bioworks's cash flow data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
